Technical notes

H.C. Wainwright analyst Yi Chen reiterated a contain rating above DENTSPLY SIRONA (NASDAQ:XRAY) Inc above Monday, location a fare tarGEt of $38, which is almost 6.52% below the gift fraction fare of $40.65. Chen expects DENTSPLY SIRONA Inc ought mail earnings per fraction (EPS) of $0.46 though the second region of 2020. The contemporary consensus among 9 TipRanks analysts is though a soft buy rating of shares at DENTSPLY SIRONA, with an averaGE fare tarGEt of $49.33. The analysts fare tarGEts ranGE from a tall of $66 ought a low of $38. In its latest earnings report, released above 12/31/2019, the corporation reported a quarterly revenue of $1.11 billion and a net use of $149.2 million. The company's impartial cap is $8.9 billion. According ought TipRanks.com, H.C. Wainwright analyst Yi Chen is a 5-star analyst with an averaGE reply of 17.3% and a 44.8% success rate. DENTSPLY SIRONA, Inc. engaGEs at the design, manufacture, sales, and distribution of professional dental products and technologies. It operates across the Technologies and Equipment, and Consumables segments. The Technologies and implement segments comprises dental technology, equipment, and healthcare consumable products such though dental implants, laboratory dental products, computer-aided pattern and computer-aided manufacturing systems, imaging systems, treatment centers, and consumable Medical implement products. The Consumables division offers preventive, restorative, instruments, endodontic, and orthodontic dental products. The corporation was founded at 2016 and is headquartered at York, PA. A professional medical service provider for Ultrasound in China---- Rongtao Medical